VREX

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Varex Imaging Corporation (NasdaqGS: VREX) to Teledyne Technologies Incorporated (NYSE: TDY). Under the terms of the proposed transaction, shareholders of Varex will receive $18.90 in cash for each share of Varex that they own. KSF is seeking to determine whether this consideration and the proc.

Teledyne Technologies (TDY) will acquire Varex Imaging (VREX) for $1.1 billion, broadening TDY's healthcare equipment portfolio and strengthening X-ray capabilities. The acquisition price of $18.90 per VREX share represents a fair 8.7x EV/EBITDA multiple, below TDY's own median multiple, adding immediate value. Post-acquisition, TDY's sales CAGR rises to nearly 10% and price target increases to $831, reflecting a 20% upside anchored in stable growth.

Although the revenue and EPS for VAREX IMAGING (VREX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago.

Teledyne Technologies said it will buy Varex Imaging for about $1.1 billion, inclusive of equity awards and debt.

Evaluate the expected performance of VAREX IMAGING (VREX) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The consensus price target hints at a 61.6% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The consensus price target hints at a 78.4% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.